AriaHealth.com

1-877-808-ARIA

Myeloma

Protocol Title Protocol Number Control Number Principal Investigator
A Randomized Phase III Study of CC-5013 plus Dexamethasone versus CC-5013 plus Low Dose Dexamethasone in Multiple Myeloma with Thalidomide plus Dexamethasone Salvage Therapy for Non-Responders (Version Date: 10/05/2005; Revised 11/05, Addendum #3; Consent dated 12/05) E4A03 FH05-119 Dr. Allen Terzian